Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
eli lilly
genentech
3
×
investing
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
agenus
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
celgene
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
johnson & johnson
national
new york blog main
new york top stories
pain drug
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
tanezumab
texas blog main
What
drug
3
×
bio
companies
fda
roundup
alzheimer’s
approval
approved
blueprint
cancer
candidate
currently
different
digital
disease
epidemic
fail
fatty
frenzied
gene
growing
increases
known
latest
led
liver
marketing
medicines
merck
muscle
nash
news
pact
pharmaceutical
plan
prescription
price
prices
race
raise
Language
unset
Current search:
genentech
×
drug
×
investing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More